Zhitong Finance App News, Zhaoyan New Pharmaceutical (06127) issued an announcement. On February 5, 2024, the company held the 6th meeting of the 4th board of directors and the first special meeting of independent directors in 2024 to review and pass the “Proposal on Cooperation between the Company and Professional Investment Institutions to Participate in the Investment Establishment of Industrial Funds and Related Transactions”, agreeing that the company and Wuxi Guolian Industrial Investment Private Equity Fund Management Co., Ltd., Beijing Hongru Heyu Investment Management Co., Ltd., and Jiangsu Yuanli Industrial Investment Co., Ltd. signed the “Wuxi Jinyifu New Biomedical Venture Capital” The “Partnership (Limited Partnership) Limited Partnership Agreement” (hereinafter referred to as the “Partnership Agreement”) jointly funded the establishment of the Wuxi Jinyifu New Biomedical Venture Capital Partnership (Limited Partnership). The total investment pledged by the fund is RMB 1 billion. As a limited partner, the company has pledged an investment of RMB 300 million, accounting for 30% of the limited partnership. The investment method is monetary investment. The relevant directors of the company have avoided voting on the bill, and it has been reviewed and approved by a special meeting of independent directors before submitting it to the board of directors for consideration.
On April 18, 2024, the company signed a “Partnership Agreement” with Wuxi Guolian Industrial Investment Private Equity Fund Management Co., Ltd., Beijing Hongru Heyu Investment Management Co., Ltd., Wuxi Innovation Investment Group Co., Ltd., Jiangsu Yuanli Industrial Investment Co., Ltd., and Xiangtang Heyuan (Beijing) Technology Co., Ltd. The total investment pledged by the fund was RMB 1 billion. The company, as a limited partner, actually pledged an investment of RMB 299 million, accounting for 29.90% of the limited partnership. The investment method was monetary investment.
The fund completed the industrial and commercial registration procedure on May 8, 2024, and obtained a “business license”.